{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:53:54Z","timestamp":1774090434672,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11906-014-0443-y","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T01:57:32Z","timestamp":1399341452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypercortisolism in Obesity-Associated Hypertension"],"prefix":"10.1007","volume":"16","author":[{"given":"Amy G.","family":"Varughese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Nimkevych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel I.","family":"Uwaifo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"issue":"1","key":"443_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7954-11-7","volume":"11","author":"L Dwyer-Lindgren","year":"2013","unstructured":"Dwyer-Lindgren L, Freedman G, Engell RE, Fleming TD, Lim SS, Murray CJ, et al. Prevalence of physical activity and obesity in US counties, 2001\u20132011: a road map for action. Popul Health Metrics. 2013;11(1):7. doi: 10.1186\/1478-7954-11-7 .","journal-title":"Popul Health Metrics"},{"issue":"3","key":"443_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA: J Am Med Assoc. 2010;303(3):235\u201341. doi: 10.1001\/jama.2009.2014 .","journal-title":"JAMA: J Am Med Assoc"},{"issue":"11 Suppl 1","key":"443_CR3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2008-1356","volume":"93","author":"ES Ford","year":"2008","unstructured":"Ford ES, Mokdad AH. Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S1\u20138. doi: 10.1210\/jc.2008-1356 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"443_CR4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.ijo.0803297","volume":"30","author":"LM Maynard","year":"2006","unstructured":"Maynard LM, Serdula MK, Galuska DA, Gillespie C, Mokdad AH. Secular trends in desired weight of adults. Int J Obes. 2006;30(9):1375\u201381. doi: 10.1038\/sj.ijo.0803297 .","journal-title":"Int J Obes"},{"key":"443_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-60761-548-4_13","volume-title":"Endocrine hypertension; Underlying mechansims and therapy","author":"GI Uwaifo","year":"2013","unstructured":"Uwaifo GI. Obesity-associated hypertension. In: Koch CA, Chrousos GP, editors. Endocrine hypertension; Underlying mechansims and therapy. New York: Humana Press; 2013. p. 251\u201388. A comprehensive discussion of the entity of obesity-associated hypertension, including its recognition, underlying pathophysiology, contributory factors and clinical associations, as well as an exhaustive discussion of the therapeutic options and how they fare in this condition as compared to typical essential hypertension."},{"issue":"5","key":"443_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","volume":"157","author":"BR Walker","year":"2007","unstructured":"Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol\/Eur Fed Endocr Soc. 2007;157(5):545\u201359. doi: 10.1530\/EJE-07-0455 .","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"5","key":"443_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.mcna.2011.06.004","volume":"95","author":"LR Kurukulasuriya","year":"2011","unstructured":"Kurukulasuriya LR, Stas S, Lastra G, Manrique C, Sowers JR. Hypertension in obesity. Med Clin N Am. 2011;95(5):903\u201317. doi: 10.1016\/j.mcna.2011.06.004 .","journal-title":"Med Clin N Am"},{"key":"443_CR8","first-page":"118","volume-title":"Hypertension; A companion to Brenner and Rector\u2019s the Kidney","author":"L Landsberg","year":"2000","unstructured":"Landsberg L. Obesity related hypertension as a metabolic disorder. In: Oparil S, Weber MA, editors. Hypertension; A companion to Brenner and Rector\u2019s the Kidney. Philadelphia: WB Saunders Company; 2000. p. 118\u201324."},{"key":"443_CR9","first-page":"206","volume-title":"Hypertension; acompanion to Brenner and Rector\u2019s the kidney","author":"E Reisin","year":"2000","unstructured":"Reisin E, Hutchison HG. Obesity-Hypertension; Effetcs on cardiovascular and renal systems; The therapeutic approach. In: Oparil S, Weber MA, editors. Hypertension; acompanion to Brenner and Rector\u2019s the kidney. Philadelphia: WB Saunders Company; 2000. p. 206\u201311."},{"issue":"1","key":"443_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","volume":"134","author":"VJ Stevens","year":"2001","unstructured":"Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001;134(1):1\u201311.","journal-title":"Ann Intern Med"},{"issue":"9294","key":"443_CR11","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","volume":"358","author":"RS Vasan","year":"2001","unstructured":"Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682\u20136. doi: 10.1016\/S0140-6736(01)06710-1 .","journal-title":"Lancet"},{"issue":"2","key":"443_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cvsm.2009.10.004","volume":"40","author":"DY Kil","year":"2010","unstructured":"Kil DY, Swanson KS. Endocrinology of obesity. Vet Clin N Am Small Anim Pract. 2010;40(2):205\u201319. doi: 10.1016\/j.cvsm.2009.10.004 .","journal-title":"Vet Clin N Am Small Anim Pract"},{"issue":"1","key":"443_CR13","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1002\/oby.20083","volume":"21","author":"SB Abraham","year":"2013","unstructured":"Abraham SB, Rubino D, Sinaii N, Ramsey S, Nieman LK. Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity. 2013;21(1):E105\u201317. doi: 10.1002\/oby.20083 . An important clinical study that details the problems with interpreting findings from HPA-axis investigation in obese subjects without overt Cushing\u2019s syndrome and reviews the conflicting literature on the findings in this regard. Also highlights the important distinction between findings regarding systemic cortisol dynamics as opposed to local tissue dynamics.","journal-title":"Obesity"},{"issue":"6","key":"443_CR14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11906-004-0046-0","volume":"6","author":"S Baid","year":"2004","unstructured":"Baid S, Nieman LK. Glucocorticoid excess and hypertension. Curr Hypertens Rep. 2004;6(6):493\u20139.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"443_CR15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.09.024","volume":"316","author":"NM Morton","year":"2010","unstructured":"Morton NM. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol. 2010;316(2):154\u201364. doi: 10.1016\/j.mce.2009.09.024 . A comprehensive discussion of the role and place of 11 beta HSD-type 1 in the normal physiology of cortisol metabolism, its role and place in obesity, hypercortisolemic states and a detailed discussion of relevant animal models, relevnace to clinical therapeutics and potential future directions in innovation and research.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"443_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.beem.2012.02.001","volume":"26","author":"M Leo De","year":"2012","unstructured":"De Leo M, Cozzolino A, Colao A, Pivonello R. Subclinical Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab. 2012;26(4):497\u2013505. doi: 10.1016\/j.beem.2012.02.001 . A topical discussion of the controversial topic of subclinical Cushing\u2019s syndrome including its prevalence, clinical presentation, diagnostic evaluation protocols with the controversies therein, as well as discussion of its association with increased cardiovascular risk, associated comorbidites including hypertension and the current available management strategies.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"443_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.beem.2006.07.006","volume":"20","author":"MA Magiakou","year":"2006","unstructured":"Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab. 2006;20(3):467\u201382. doi: 10.1016\/j.beem.2006.07.006 .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"443_CR18","doi-asserted-by":"crossref","unstructured":"Sharma ST, Nieman LK. Cushing\u2019s syndrome: all variants, detection, and treatment. Endocrinology and metabolism clinics of North America. 2011;40(2):379-91, viii-ix. doi: 10.1016\/j.ecl.2011.01.006 . A thorough review of the various etiolic considerations in the differential diagnosis of Cushing\u2019s syndrome and other hypercortisolemic states, their association with hypertension, and a discussion of the available therapeutic options.","DOI":"10.1016\/j.ecl.2011.01.006"},{"issue":"1","key":"443_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0039-128X(94)00033-9","volume":"60","author":"JA Whitworth","year":"1995","unstructured":"Whitworth JA, Brown MA, Kelly JJ, Williamson PM. Mechanisms of cortisol-induced hypertension in humans. Steroids. 1995;60(1):76\u201380.","journal-title":"Steroids"},{"issue":"3","key":"443_CR20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.jhh.1000959","volume":"14","author":"JJ Kelly","year":"2000","unstructured":"Kelly JJ, Martin A, Whitworth JA. Role of erythropoietin in cortisol-induced hypertension. J Hum Hypertens. 2000;14(3):195\u20138.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"443_CR21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0960-0760(92)90077-V","volume":"43","author":"F Mantero","year":"1992","unstructured":"Mantero F, Boscaro M. Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol. 1992;43(5):409\u201313.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"443_CR22","doi-asserted-by":"crossref","unstructured":"Ong SL, Whitworth JA. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinology and metabolism clinics of North America. 2011;40(2):393-407, ix. doi: 10.1016\/j.ecl.2011.01.010 . A comprehensive discussion of the basic and animal model-based data that detail the role of glucocorticoids in influencing vascular tone, compliance and endothelial reactivity, as well as the relevance of this to the development of glucocorticoid-induced hypertension in both animal models and human patients.","DOI":"10.1016\/j.ecl.2011.01.010"},{"issue":"9","key":"443_CR23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1507\/endocrj.EJ11-0030","volume":"58","author":"DS Chandran","year":"2011","unstructured":"Chandran DS, Jaryal AK, Jyotsna VP, Deepak KK. Impaired endothelium mediated vascular reactivity in endogenous Cushing\u2019s syndrome. Endocr J. 2011;58(9):789\u201399.","journal-title":"Endocr J"},{"issue":"4","key":"443_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","volume":"1","author":"JA Whitworth","year":"2005","unstructured":"Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005;1(4):291\u20139.","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"443_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570161043476483","volume":"2","author":"S Yang","year":"2004","unstructured":"Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. 2004;2(1):1\u201312.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"443_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EJE-11-0601","volume":"166","author":"KH Yiu","year":"2012","unstructured":"Yiu KH, Marsan NA, Delgado V, Biermasz NR, Holman ER, Smit JW, et al. Increased myocardial fibrosis and left ventricular dysfunction in Cushing\u2019s syndrome. Eur J Endocrinol\/Eur Fed Endocr Soc. 2012;166(1):27\u201334. doi: 10.1530\/EJE-11-0601 .","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"2","key":"443_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/hr.2013.124","volume":"37","author":"T Hattori","year":"2014","unstructured":"Hattori T, Murase T, Sugiura Y, Nagasawa K, Takahashi K, Ohtake M, et al. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury. Hypertens Res: Off J Jpn Soc Hypertens. 2014;37(2):125\u201333. doi: 10.1038\/hr.2013.124 .","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"issue":"5","key":"443_CR28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF03346381","volume":"31","author":"F Ermetici","year":"2008","unstructured":"Ermetici F, Malavazos AE, Corbetta S, Eller-Vainicher C, Cannavo S, Corsi MM, et al. Soluble adhesion molecules levels in patients with Cushing\u2019s syndrome before and after cure. J Endocrinol Investig. 2008;31(5):389\u201392.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"443_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF03346383","volume":"31","author":"C Kristo","year":"2008","unstructured":"Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J. Biochemical markers for cardiovascular risk following treatment in endogenous Cushing\u2019s syndrome. J Endocrinol Investig. 2008;31(5):400\u20135.","journal-title":"J Endocrinol Investig"},{"issue":"8","key":"443_CR30","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2004-0079","volume":"89","author":"M Terzolo","year":"2004","unstructured":"Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, et al. Hyperhomocysteinemia in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metabol. 2004;89(8):3745\u201351. doi: 10.1210\/jc.2004-0079 .","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"443_CR31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1681.2011.05538.x","volume":"39","author":"K Oki","year":"2012","unstructured":"Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE. Role of mineralocorticoid action in the brain in salt-sensitive hypertension. Clin Exp Pharmacol Physiol. 2012;39(1):90\u20135. doi: 10.1111\/j.1440-1681.2011.05538.x .","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"443_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF03343591","volume":"22","author":"M Duclos","year":"1999","unstructured":"Duclos M, Corcuff JB, Etcheverry N, Rashedi M, Tabarin A, Roger P. Abdominal obesity increases overnight cortisol excretion. J Endocrinol Investig. 1999;22(6):465\u201371.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"443_CR33","first-page":"647","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev. 1998;19(5):647\u201372. doi: 10.1210\/edrv.19.5.0346 .","journal-title":"Endocr Rev"},{"issue":"4","key":"443_CR34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2005-861374","volume":"37","author":"M Salehi","year":"2005","unstructured":"Salehi M, Ferenczi A, Zumoff B. Obesity and cortisol status. Horm Metab Res Horm Stoffwechselforschung Horm Metabol. 2005;37(4):193\u20137. doi: 10.1055\/s-2005-861374 .","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metabol"},{"issue":"8","key":"443_CR35","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","volume":"94","author":"P Anagnostis","year":"2009","unstructured":"Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94(8):2692\u2013701. doi: 10.1210\/jc.2009-0370 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"443_CR36","first-page":"1","volume":"52","author":"IB Ahluwalia","year":"2003","unstructured":"Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS. State-specific prevalence of selected chronic disease-related characteristics\u2013Behavioral Risk Factor Surveillance System, 2001. Morbid Mortal Wkly Rep Surveill Summ. 2003;52(8):1\u201380.","journal-title":"Morbid Mortal Wkly Rep Surveill Summ"},{"issue":"9060","key":"443_CR37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","volume":"349","author":"IJ Bujalska","year":"1997","unstructured":"Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect \u201cCushing\u2019s disease of the omentum\u201d? Lancet. 1997;349(9060):1210\u20133. doi: 10.1016\/S0140-6736(96)11222-8 .","journal-title":"Lancet"},{"key":"443_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1749-6632.2012.06569.x","volume":"1264","author":"R Pasquali","year":"2012","unstructured":"Pasquali R. The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects. Ann N Y Acad Sci. 2012;1264:20\u201335. doi: 10.1111\/j.1749-6632.2012.06569.x .","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"443_CR39","first-page":"341","volume":"77","author":"R Pasquali","year":"1993","unstructured":"Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 1993;77(2):341\u20136. doi: 10.1210\/jcem.77.2.8393881 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"443_CR40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccl.2010.07.002","volume":"28","author":"MC Acelajado","year":"2010","unstructured":"Acelajado MC, Calhoun DA. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment. Cardiol Clin. 2010;28(4):639\u201354. doi: 10.1016\/j.ccl.2010.07.002 .","journal-title":"Cardiol Clin"},{"issue":"5","key":"443_CR41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00125-004-1389-4","volume":"47","author":"W Aldhahi","year":"2004","unstructured":"Aldhahi W, Mun E, Goldfine AB. Portal and peripheral cortisol levels in obese humans. Diabetologia. 2004;47(5):833\u20136. doi: 10.1007\/s00125-004-1389-4 .","journal-title":"Diabetologia"},{"issue":"1","key":"443_CR42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2337\/db08-0969","volume":"58","author":"RH Stimson","year":"2009","unstructured":"Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC, et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes. 2009;58(1):46\u201353. doi: 10.2337\/db08-0969 .","journal-title":"Diabetes"},{"issue":"5","key":"443_CR43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1337986","volume":"45","author":"B Alfonso","year":"2013","unstructured":"Alfonso B, Araki T, Zumoff B. Is there visceral adipose tissue (VAT) intracellular hypercortisolism in human obesity? Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2013;45(5):329\u201331. doi: 10.1055\/s-0033-1337986 .","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"443_CR44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1741-7015-11-44","volume":"11","author":"F Prodam","year":"2013","unstructured":"Prodam F, Ricotti R, Agarla V, Parlamento S, Genoni G, Balossini C, et al. High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study. BMC Med. 2013;11:44. doi: 10.1186\/1741-7015-11-44 .","journal-title":"BMC Med"},{"key":"443_CR45","first-page":"682","volume-title":"Hypertension; a companion to Brenner and Rector\u2019s the kidney","author":"EL Bravo","year":"2000","unstructured":"Bravo EL. The adrenal cortex. In: Oparil S, Weber MA, editors. Hypertension; a companion to Brenner and Rector\u2019s the kidney. Philadelphia: WB Saunders Company; 2000. p. 682\u20135."},{"issue":"5","key":"443_CR46","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340. doi: 10.1210\/jc.2008-0125 .","journal-title":"J Clin Endocrinol Metab"},{"key":"443_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-60761-548-4_3","volume-title":"Endocrine hypertension; Underlying mechansims and therapy","author":"V Kantorovich","year":"2013","unstructured":"Kantorovich V, Koch CA, Chrousos GP. Hypertension in patients with Cushing\u2019s syndrome. In: Koch CA, Chrousos GP, editors. Endocrine hypertension; Underlying mechansims and therapy. New York: Humana press; 2013. p. 51\u201368. A comprehensive review of the etiopathogenesis of hypertension in Cushing\u2019s syndrome, the treatment options, and its relevance to hypertension in obesity in general."},{"issue":"4878","key":"443_CR48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242(4878):583\u20135.","journal-title":"Science"},{"issue":"1","key":"443_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","volume":"10","author":"JW Funder","year":"2005","unstructured":"Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev. 2005;10(1):15\u201322. doi: 10.1007\/s10741-005-2344-2 .","journal-title":"Heart Fail Rev"},{"issue":"4","key":"443_CR50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.2000.00963.x","volume":"57","author":"D Pearce","year":"2000","unstructured":"Pearce D, Verrey F, Chen SY, Mastroberardino L, Meijer OC, Wang J, et al. Role of SGK in mineralocorticoid-regulated sodium transport. Kidney Int. 2000;57(4):1283\u20139. doi: 10.1046\/j.1523-1755.2000.00963.x .","journal-title":"Kidney Int"},{"issue":"3","key":"443_CR51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1523-1755.2000.00919.x","volume":"57","author":"O Staub","year":"2000","unstructured":"Staub O, Abriel H, Plant P, Ishikawa T, Kanelis V, Saleki R, et al. Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int. 2000;57(3):809\u201315. doi: 10.1046\/j.1523-1755.2000.00919.x .","journal-title":"Kidney Int"},{"issue":"8994","key":"443_CR52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","volume":"347","author":"PM Stewart","year":"1996","unstructured":"Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet. 1996;347(8994):88\u201391.","journal-title":"Lancet"},{"issue":"6","key":"443_CR53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000441-200112000-00003","volume":"322","author":"PC White","year":"2001","unstructured":"White PC. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci. 2001;322(6):308\u201315.","journal-title":"Am J Med Sci"},{"issue":"5","key":"443_CR54","first-page":"S19","volume":"14","author":"CB Whorwood","year":"1996","unstructured":"Whorwood CB, Stewart PM. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. J Hypertens Suppl: Off J Int Soc Hypertens. 1996;14(5):S19\u201324.","journal-title":"J Hypertens Suppl: Off J Int Soc Hypertens"},{"issue":"4","key":"443_CR55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","volume":"13","author":"FJ Frey","year":"2004","unstructured":"Frey FJ, Odermatt A, Frey BM. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr Opin Nephrol Hypertens. 2004;13(4):451\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4\u20136","key":"443_CR56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0960-0760(91)90269-B","volume":"40","author":"PM Stewart","year":"1991","unstructured":"Stewart PM, Edwards CR. The cortisol-cortisone shuttle and hypertension. J Steroid Biochem Mol Biol. 1991;40(4\u20136):501\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"443_CR57","doi-asserted-by":"crossref","unstructured":"Strohmayer EA, Krakoff LR. Glucocorticoids and cardiovascular risk factors. Endocrinology and metabolism clinics of North America. 2011;40(2):409-17, ix. doi: 10.1016\/j.ecl.2011.01.011 .","DOI":"10.1016\/j.ecl.2011.01.011"},{"issue":"21","key":"443_CR58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2169\/internalmedicine.45.1809","volume":"45","author":"I Minami","year":"2006","unstructured":"Minami I, Tateno T, Yoshimoto T, Doi M, Izumiyama H, Akashi T, et al. Subclinical Cushings disease with amelioration of metabolic comorbidities after removal of pituitary tumor. Intern Med. 2006;45(21):1231\u20135.","journal-title":"Intern Med"},{"issue":"6","key":"443_CR59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2796.1993.tb01018.x","volume":"234","author":"F Fallo","year":"1993","unstructured":"Fallo F, Paoletta A, Tona F, Boscaro M, Sonino N. Response of hypertension to conventional antihypertensive treatment and\/or steroidogenesis inhibitors in Cushing\u2019s syndrome. J Intern Med. 1993;234(6):595\u20138.","journal-title":"J Intern Med"},{"issue":"1","key":"443_CR60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0895-7061(95)00299-5","volume":"9","author":"F Fallo","year":"1996","unstructured":"Fallo F, Sonino N, Barzon L, Pistorello M, Pagotto U, Paoletta A, et al. Effect of surgical treatment on hypertension in Cushing\u2019s syndrome. Am J Hypertens. 1996;9(1):77\u201380.","journal-title":"Am J Hypertens"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-014-0443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-014-0443-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-014-0443-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:14:34Z","timestamp":1559420074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-014-0443-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1007\/s11906-014-0443-y","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]},"article-number":"443"}}